The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Target Validation, 2005Inhibitors of Poly (ADP-Ribose) Glycohydrolase (PARG) as Novel Agents for the Treatment of PD
It has become increasingly clear that the death of mid-brain neurons in Parkinson's disease patients is associated with the activation of certain enzymes that add sugar units onto various proteins. In...
-
Clinical Discovery Awards, 2005Phase I Study of CERE-120 [Adeno-Associated Virus (AAV)-Neuturin (NTN)] to Assess the Safety and Tolerability of Intraputaminal Delivery
Objective/Rationale:
Neurotrophic factors including neurturin (NTN) have been shown to effectively augment the function and prevent the death of dopaminergic nigrostriatal neurons in animal models of... -
MJFF Research Grant, 2005Nebraska Parkinson's Disease Registry
The American Parkinson Disease Association (APDA) and The Michael J. Fox Foundation for Parkinson's Research (MJFF) are co-funding the Nebraska Parkinson's Disease Registry with a three-year...
-
LEAPS, 2005Michael J. Fox Foundation Validation Study
The role of genetics in PD continues to be a major focus in the field and much of what we know about possible underlying mechanisms of PD cause and pathogenesis has come through studies of genes (e.g...
-
Clinical Discovery Awards, 2005Executive, ADL, and Cholinergic Functions in PD
Parkinson's disease is a disorder that is most known for motor impairments of tremor, slowness in moving, and loss of balance. Patients with Parkinson's disease also suffer from non-motor symptoms...
-
Clinical Discovery Awards, 2005Ability to Slow Disease Progression and Safety and Tolerability of Green Tea Polyphenols in Early Parkinson’s Disease
Objective/Rationale:
Previous studies have shown that tea drinking is associated with a reduced of risk for Parkinson's disease (PD). Green tea polyphenols (GTPs), the major components of green tea...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.